Breakthrough Cholesterol Treatment
Thomas discusses the efficacy of PCSK9 inhibitors in primary prevention, highlighting their potential in reducing ApoB levels. Despite being costly, these injectable drugs show promise in lowering LDL cholesterol through an LDL receptor mechanism, making them a viable option for high-risk individuals with atherosclerosis.In this clip
From this podcast
The Proof with Simon Hill
Preventing and treating cardiovascular disease (Lipid Series - Part 3) | Dr Thomas Dayspring
Related Questions
How do PCSK9 inhibitors reduce apoB in the context of the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?